Colorectal Cancer
VIDEO: ‘Never been more important’ to discuss value of CRC screening, early detection
In a Healio video exclusive, David M. Poppers, MD, PhD, explains why “now is the most important time” for colorectal cancer screening and how physicians can help make patients more comfortable with colonoscopy.
Older female colorectal cancer survivors often experience persistent GI symptoms
More than 80% of older women who survived colorectal cancer experienced a range of gastrointestinal symptoms that sometimes persisted for decades, according to data published in PLOS One.
Divarasib induces durable responses in KRAS-mutated solid tumors
Divarasib induced durable clinical responses among patients with KRAS G12C-positive solid tumors, according to study findings published in The New England Journal of Medicine.
Cancer trial toxicity reporting inconsistent, often uses ‘subjective minimizing language’
Abstracts of randomized phase 3 clinical trials in gastrointestinal oncology frequently use subjective minimizing language to characterize serious toxicities, according to results of a systematic review presented at ASCO Annual Meeting.
Healio Gastroenterology rehash: Trending topics (so far); what do you want to read about?
From the impact of Humira biosimilars flooding the U.S. market to shifting trends in colorectal cancer demographics, Healio has asked experts the big questions to stay abreast of the current hot topics in gastroenterology and hepatology.
Q&A: Oncologist’s colorectal cancer diagnosis ‘changed the way I interact with patients’
A cancer diagnosis can be terrifying for any patient, but when a colorectal cancer researcher is diagnosed with the same disease that they spent years studying, it also transforms how they practice medicine and how they relate to patients.
Lowering CRC screening age to 40 years could result in up to 7,988 fewer deaths in Canada
A microsimulation model showed a reduction in colorectal cancer disease burden and mortality when screening for CRC was initiated at ages 45 years or 40 years, which also added life-years to the population at a comparable health care cost.
Q&A: ABGH summit spotlights mentorship, ‘handing the baton’ to future leaders in GI
The American Association for Black Gastroenterologists and Hepatologists’ inaugural Gut Health Summit shined a light on the historical, current and future state of heath equity for Black patients with GI and liver diseases.
Time to treatment does not affect survival for younger adults with colorectal cancer
Time from presentation to treatment did not affect survival among adults aged younger than 50 years with colorectal cancer, according to study results published in JAMA Network Open.
Surgery improves symptoms for patients with advanced cancer, malignant bowel obstruction
Surgery did not significantly increase the number of “good days” among patients with advanced cancer and malignant small bowel obstruction, according to study results.